Novartis
NVS
1,604 hedge funds and large institutions have $22B invested in Novartis in 2026 Q1 according to their latest regulatory filings, with 197 funds opening new positions, 534 increasing their positions, 551 reducing their positions, and 88 closing their positions.
124% more first-time investments, than exits
New positions opened: 197 | Existing positions closed: 88
20% more capital invested
Capital invested by funds: $18.4B → $22B (+$3.65B)
6% more funds holding in top 10
Funds holding in top 10: 16 → 17 (+1)
6% more funds holding
Funds holding: 1,515 → 1,604 (+89)
0.62% more ownership
Funds ownership: 6.95% → 7.56% (+0.62%)
3% less repeat investments, than reductions
Existing positions increased: 534 | Existing positions reduced: 551
53% less call options, than puts
Call options by funds: $320M | Put options by funds: $681M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$984M |
| 2 |
Goldman Sachs
New York
|
+$579M |
| 3 |
Jones Financial Companies
Des Peres,
Missouri
|
+$249M |
| 4 |
WCM Investment Management
Laguna Beach,
California
|
+$224M |
| 5 |
Natixis Advisors
Boston,
Massachusetts
|
+$214M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
-$314M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$164M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$111M |
| 4 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$109M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$104M |
NVS Hedge Fund Activity: Q1 2026 in Review
1,604 of the 8,207 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q1 2026, worth a combined $22B — up 20% from $18.4B a quarter earlier.
Buyers outnumbered sellers: 197 funds opened new NVS positions and 88 closed out — a net gain of 109 holders — while 534 added to existing stakes and 551 trimmed.
The largest buyer was Fisher Asset Management, adding an estimated $984M. The largest seller was Dodge & Cox, cutting an estimated $314M.
- 1,604 institutional investors held Novartis (NVS) as of Q1 2026, up from 1,515 in Q4 2025.
- Funds reported $22B of Novartis stock for Q1 2026, up 20% quarter-over-quarter.
- 197 funds opened new Novartis positions in Q1 2026 and 88 closed out, a net change of +109 holders.
- The largest Novartis buyer in Q1 2026 was Fisher Asset Management, an estimated $984M added.
- The largest Novartis seller in Q1 2026 was Dodge & Cox, an estimated $314M sold.
Based on aggregated 13F filings for Q1 2026.